Hims & Hers Health, Inc. Class Action: The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 – HIMS

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of misleading statements and deceptive practices related to the promotion of illegitimate products, which may jeopardize its collaboration with Novo Nordisk [3]. Group 1: Allegations and Class Period - The class period for the lawsuit is from April 29, 2025, to June 23, 2025 [3]. - Allegations include that Hims engaged in the deceptive promotion and selling of knockoff versions of Wegovy®, risking patient safety [3]. - The lawsuit claims that the company's positive statements about its business and prospects were materially misleading and lacked a reasonable basis due to these practices [3]. Group 2: Shareholder Information - Shareholders who purchased HIMS shares during the class period are encouraged to register for the class action, with a deadline of August 25, 2025, to seek lead plaintiff status [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].